首页> 外文期刊>Nature Communications >Inhibitor binding mode and allosteric regulation of Na + -glucose symporters
【24h】

Inhibitor binding mode and allosteric regulation of Na + -glucose symporters

机译:Na +-葡萄糖同向转运蛋白的抑制剂结合模式和变构调控

获取原文
           

摘要

Sodium-dependent glucose transporters (SGLTs) exploit sodium gradients to transport sugars across the plasma membrane. Due to their role in renal sugar reabsorption, SGLTs are targets for the treatment of type 2 diabetes. Current therapeutics are phlorizin derivatives that contain a sugar moiety bound to an aromatic aglycon tail. Here, we develop structural models of human SGLT1/2 in complex with inhibitors by combining computational and functional studies. Inhibitors bind with the sugar moiety in the sugar pocket and the aglycon tail in the extracellular vestibule. The binding poses corroborate mutagenesis studies and suggest a partial closure of the outer gate upon binding. The models also reveal a putative Na+ binding site in hSGLT1 whose disruption reduces the transport stoichiometry to the value observed in hSGLT2 and increases inhibition by aglycon tails. Our work demonstrates that subtype selectivity arises from Na+-regulated outer gate closure and a variable region in extracellular loop EL5.
机译:钠依赖性葡萄糖转运蛋白(SGLT)利用钠梯度将糖跨质膜转运。由于它们在肾糖重吸收中的作用,SGLTs是治疗2型糖尿病的靶标。当前的治疗剂是Phlorizin衍生物,其包含结合至芳香族糖苷配基尾部的糖部分。在这里,我们通过结合计算和功能研究来开发与抑制剂复合的人SGLT1 / 2的结构模型。抑制剂与糖袋中的糖部分和细胞外前庭中的糖苷配基尾结合。这种结合构成了正确的诱变研究,并暗示了结合后外门的部分关闭。该模型还揭示了hSGLT1中一个推测的Na +结合位点,其破坏将转运化学计量降低到hSGLT2中观察到的值,并增加了糖苷配基尾部的抑制作用。我们的工作表明亚型选择性源自Na +调节的外门关闭和细胞外环EL5中的可变区。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号